we propose that the main function of m 6 A is post-transcriptional fine-tuning of gene expression.
In contrast to miRNA regulation, which mostly reduces gene expression, we argue that m 6 A provides a fast mean to post-transcriptionally maximise gene expression. Additionally, m 6 A appears to have a second function during developmental transitions by targeting m 6 A-marked transcripts for degradation.
Ancient modifications in RNA
Modified nucleotides were first discovered in transfer RNAs (tRNA) and ribosomal RNAs (rRNA), and these modifications are present in all organisms [1] [2] [3] [4] . Some of the same nucleotide modifications were later identified in messenger RNAs (mRNA) of prokaryotes, eukaryotes and viruses, revealing an entire new layer of regulation of gene expression [5] [6] [7] [8] , which has been termed epitranscriptomics (Box 1) [9] .
Recent technological advances in high-throughput sequencing in combination with antibody-enrichment and/or induced nucleotide-specific chemical modifications have accelerated the mapping of modifications both on abundant tRNAs and rRNAs and on the less abundant mRNAs [9] [10] [11] [12] [13] [14] [15] [16] . A striking observation of these studies was the prevalence of few modifications in mRNA and their non-random distribution, implying important regulatory functions.
Furthermore, they can be dynamic and exhibit changes in distribution or frequency in response to various stresses. N 6 -methyladenosine (m 6 A) is the most common internal modification in mRNA and long non-coding RNA [9, 12] . m 6 A profiling experiments in higher eukaryotes revealed its conserved enrichment near stop codons, long internal exons and, less commonly, start codons. In addition, m 6 A has also been found enriched in ribosome-associated mRNA [17] [18] [19] . Genetic loss-offunction studies for m 6 A methyltransferases (m 6 A writers), m 6 A-binding proteins (m 6 A readers) and m 6 A demethylases (m 6 A erasers) (see Box 2 and Figure 1 ) have highlighted a critical role for the m 6 A modification in the control of gene expression in several physiological processes (for recent reviews see [6, 20] ).
However, it is still not clear precisely how m 6 A affects gene expression and what benefit cells and organisms obtain from this extra regulatory layer. A number of recent studies characterizing the role of m 6 A in alternative splicing and translational regulation provide insights into the more general function of m 6 A in gene expression at the molecular level [17, 18, 19, 28, 32, 41] . Based on these observations detailed and discussed below, we propose that a main function of m 6 A is to fine-tune gene expression.
Functions of m 6 A in development, cellular differentiation and disease
Insights into the function of m 6 6 A methylation occurs whilst pre-mRNA is being transcribed [19] . The presence of m 6 A then influences subsequent events in mRNA processing and function in several ways (see below, Figure 1 ). These include effects on alternative pre-mRNA splicing, 3'-end processing, nuclear export, translation and mRNA decay [6] . Other possible functions not yet explored might include transcriptional regulation and control of RNA localization.
Pre-mRNA splicing:
In mammals, components of the methyltransferase complex localize to speckles, where splicing occurs [44] [45] [46] . Since m 6 A is found in introns and affects alternative splicing of Sxl pre-mRNA, installation of m 6 A epimarks must occur co-transcriptionally and before splicing ( Figure 1 ) [12, 19] .
Likewise m 6 A now has proven roles in regulation of alternative splicing, but it seems not to have a role in localizing splice sites in large introns [19, 32, 47] . For instance, m 6 A present in alternative exons induces their inclusion by directly recruiting the m 6 A-binding reader YTHDC1 [48] . YTHDC1 then recruits the splicing factor SRSF3, promoting exon inclusion, and restricts binding of the exon-skipping factor SRSF10 [48] .
Lack of m 6 A in Drosophila mRNAs changes alternative splicing in ~2% of genes, with a strong preference (75%) for alternative splicing in 5'UTRs. Here, m 6 A directed alternative splicing regulation decreases the number of upstream AUGs in 5'UTRs, suggesting that m 6 Aregulated alternative splicing increases translational of the main ORF [19, 32] . The experimentally measured m 6 A levels after a guanosine in Drosophila mRNAs are low [19] , but it remains uncertain whether m 6 A in Drosophila is preferentially in an AAC context, or might initially be incorporated but then be removed -either by uncharacterized demethylases (see below) or in excised and rapidly degraded introns.
In Sxl pre-mRNA in Drosophila, m 6 A is present in introns on either side of the malespecific alternatively spliced exon that encodes a premature stop codon [19] . This makes expression of Sxl female-specific, so that sex determination can occur. To fully exclude this exon in females, Sxl binds on either side in the intron, in the vicinity of the m 6 A sites, and requires assistance from the m 6 A reader YT521-B for full suppression of exon inclusion to achieve maximum Sxl expression. Besides its role in sex determination, Sxl has a second function in dosage compensation. Here, Sxl is required for very tight translational suppression of msl-2 in females. In males, Msl-2 directs up-regulation of transcription from the single X chromosome to neutralize the unequal numbers of X chromosomes between males and females [19] . The presence of a trace of Msl-2 in females will trigger dosage compensation and compromise viability. Hence, presence of m 6 A in the Sxl intron ensures by enhancing splicing that the maximum amount of Sxl is made to prevent ectopic dosage compensation in females.
The N 6 -methyl group in adenosine weakens base-pairing, which can alter RNA structure
[49]. Such structural changes, also termed m 6 A switch, have been associated with increased binding of hnRNPC and hnRNPG, and concomitant changes in alternative splicing [50, 51] .
Whether m 6 A binding by the YTH domain proteins participate in this regulation, however, remains to be determined. suggesting cell type specific differences in the interpretation of m 6 A epimarks [53] .
Nuclear export: Loss of the ALKBH5 eraser increases m 6 A in mRNA and results in more mRNA in the cytoplasm, suggesting that m 6 A-containing mRNAs are more readily exported from the nucleus [54] . Lack of m 6 A also resulted in delayed appearance of clock gene transcripts in the cytoplasm resulting in an extension of the daily period [25] . Moreover, m 6 A is required for nuclear export of HIV-1 transcripts [55, 56] .
Regulation of translation:
An early observation was that the presence of m 6 A stimulated the translation of mouse dihydrofolate reductase mRNA using an in vitro rabbit reticulocyte translation system [57] . Consistent with a more general role in regulating translation, m 6 A in regulating translation may vary depending on cell type and developmental status.
Another mechanism for the regulation of translation by m 6 A comes into play during stress responses (e.g. to UV or heat shock). Here, preferential m 6 A methylation of the 5'UTR of stress response genes leads to cap-independent translation, which involves nuclear re-localization of YTHDF2 to prevent m 6 A removal by the Fat-mass and obesity (FTO) demethylase [61, 62] .
FTO has been shown to act primarily on N 6 -methyladenosine that is introduced at the first position after the cap by a currently unknown methyltransferase and shows preference for m 6 A that is also 2'-O-methylated (m 6 Am) [63] .
mRNA decay: m 6 A has also been implicated in regulating mRNA decay. When transcription was halted with actinomycin D in cells lacking m 6 A writer the decay of many mRNAs was slowed
[27, [64] [65] [66] . In contrast, 80% inhibition of m 6 A methylation by an S-adenosylhomocysteine analogue in HeLa delayed appearance of pulse-labelled mRNA in the cytoplasm, probably due to mRNA processing or export defects, but did not change the average half-life of all mRNAs [67].
In mouse embryonic stem (ES) cells m 6 A targets transcripts mediating pluripotency and lineage commitment for degradation [23, 26] . In addition, the reader YTHDF2 is required for clearance of maternal mRNA at the MZT early in zebrafish embryonic development [42] . These observations argue that m 6 A has a role in promoting mRNA decay, but this function might be restricted to certain cell types such as ES cells or to specific developmental transitions. A mutational analysis of m 6 A in labile transcripts would be required to determine whether m 6 A does indeed target transcripts for degradation.
In mammals, the YTH domain-containing protein YTHDF2 recognizes m 6 A through its YTH C-terminal domain and directs mRNA to cytoplasmic P-bodies by recruiting the CCR4-NOT deadenylase complex, initiating deadenylation and degradation of methylated transcripts [65, 68] . Recently, YTHDF3, another cytoplasmic protein, was shown to interact co-operatively with YTHDF2 to accelerate mRNA decay [66] . YTHDF3 in co-operation with a third YTH protein, YTHDF1 also promotes translation of methylated RNAs [66, A further role for m 6 A in promoting translation has been revealed during heat-shock stress. Under such conditions of general shut down-of gene expression, m 6 A in the 5'UTR can direct selective translation of transcripts after de-capping [61, 62] . UV-light induced DNA damage also relies on m 6 A, but whether this involves enhanced translation e.g. of DNA repair enzymes needs to be elaborated [77] .
A different role in enhancing protein production has been assigned to N 6 -methyladenosine when in the cap adjacent position. Here, m 6 A and m 6 Am directly counteract miRNA mediated de-capping [63] .
Another mechanism for making more protein has been revealed in the Drosophila sex determination pathway where the amount of female-specific Sxl is most critical for fully suppressing dosage compensation. Here, m 6 A in the introns flanking an alternatively spliced exon is required to enhance skipping of this exon, whose inclusion results in a truncated non-functional Sxl protein. In fact, m 6 A present in alternative exons has also been shown to enhance their inclusion likely resulting in higher protein levels of longer isoforms [48] .
In human dosage compensation, m 6 A enhances the function of the non-coding RNA Xist in inactivating one of the X chromosomes in females. The exact mechanism how m 6 A in Xist drives condensation of the chromatin of this X chromosome, however, is not known [28] .
In support of such a ubiquitous role of m 6 A in adjusting gene expression, we find methyltransferase complex components associated with most if not all RNA Pol II transcribed genes in Drosophila [19] . Since Drosophila is weakly viable without m 6 A, this suggests that m 6 A is mostly used for non-vital aspects of gene expression to increase fitness and adaptability.
Since many miRNA mutants also display very mild phenotypes (reviewed in [75] ) a main role for m 6 A in Drosophila to counteract miRNA regulation appears possible.
The presence of demethylases remains to be demonstrated in Drosophila, but they could be absent. In addition, it is also not clear whether m 6 A affects mRNA stability and pri-miRNA processing in Drosophila. It remains to be determined, however, whether m 6 A is differentially recognized by YTH domain proteins for transcript-specific fates in different cell-types or whether m 6 A is used in a cell type-specific manner to either direct translational enhancement or mRNA decay. Potentially, transcript specific outcomes could be generated through interaction of YTH proteins with other RNA binding proteins such as Sxl or related ELAV/Hu family proteins [12, 19, 80] .
Functional antagonism between
In addition, demethylases can remove m 6 A epimarks, but this is not simply a cytoplasmic pathway to remove nuclear installed m 6 A as ALKBH5 localizes to nuclear speckles and FTO shuttles between the nucleus and the cytoplasm [54, 63] .
Concluding Remarks
The novel field of epitranscriptomics has yielded fundamental progress in defining the topology of mRNA modifications genome-wide -and especially of m 6 A, the most abundant modification.
Further technological advances will be needed before we can measure low and dynamic changes pombe and the nematode C. elegans [88, 89] , suggesting that m 6 A on mRNA is not present in these organisms.
Readers: YTH domain-containing proteins have recently been identified as readers of m 6 A marks on mRNA. They display a 10-50-fold higher affinity for m 6 A methylated mRNA than for unmethylated mRNA [19, [90] [91] [92] [93] . Animals have two families of YTH proteins. One has two members in humans (YTHDC1 and YTHDC2) and one in Drosophila (YT521-B), and the other has three members in humans (YTHDF1/2/3) and one in Drosophila (CG6422). Plants have many more (13 in Arabidopsis) [88] . In the nematode C. elegans, YTH proteins are also absent [88] .
Erasers: m 6 A can be reverted to adenosine by the m 6 A RNA demethylase ALKBH5 in mammals, but whether demethylases exist in lower eukaryotes remains to be determined [54] . A second demethylase from mammals, Fat Mass and Obesity-associated protein (FTO) was initially thought to play a similar function, but a recent report suggests that its in vivo activity is rather dedicated towards the methylation present when the first cap adjacent nucleotide is an adenosine. The enzyme placing this m 6 A modification is not yet known [54, 63, 94, 95] . 
Mmi1
YTH domain-containing protein, which lost its ability to recognize m 6 A and directs yeast meiotic mRNAs to degradation via binding to the DRS.
METTL3 (Methyltransferase like 3)
methyltransferase involved in m 6 A deposition on mRNA, also named MTA-70, MTA and IME4.
METTL14 (Methyltransferase like 14)
component of the m 6 A methyltransferase complex that serves as a support protein for METTL3, but seems catalytically inactive.
RBM15 (RNA Binding Motif Protein 15)
Member of the Split-end family of protein and component of the m 6 A methyltransferase complex that recruits the methylosome to its target mRNAs Sxl (Sex lethal) master regulator of the sex determination and dosage compensation pathways in Drosophila.
SRSF3 (Serine and Argine Rich Splicing Factor 3)
splicing factor recruited to pre-mRNA near m 6 A sites via the m 6 A reader YTHDC1, resulting in exon inclusion
SRSF10 (Serine and Arginine Rich Splicing Factor 10)
Splicing factor that interacts with the m 6 A reader YTHDC1, preventing its binding to mRNA close to m 6 A-containing regions, leading to exon skipping.
WTAP (Wilms Tumor 1 Associated Protein)
subunit of the methyltransferase complex that stabilizes the integrity of the heterodimer METTL3/METTL14. 
YTH proteins

